XML 22 R15.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Fair Value Of Financial Instruments
3 Months Ended
Dec. 31, 2019
Fair Value Disclosures [Abstract]  
Fair Value Of Financial Instruments FAIR VALUE OF FINANCIAL INSTRUMENTS
Fair Value Measurements - The Company uses fair value measurements to record fair value adjustments to certain financial instruments and to determine fair value disclosures in accordance with Accounting Standards Codification ("ASC") 820 and ASC 825. The Company's AFS securities and interest rate swaps are recorded at fair value on a recurring basis. Additionally, from time to time, the Company may be required to record at fair value other financial instruments on a non-recurring basis, such as OREO and loans individually evaluated for impairment. These non-recurring fair value adjustments involve the application of lower of cost or fair value accounting or write-downs of individual financial instruments.

The Company groups its financial instruments at fair value in three levels based on the markets in which the financial instruments are traded and the reliability of the assumptions used to determine fair value. These levels are:

Level 1 - Valuation is based upon quoted prices for identical instruments traded in active markets.
Level 2 - Valuation is based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market.
Level 3 - Valuation is generated from model-based techniques that use significant assumptions not observable in the market. These unobservable assumptions reflect the Company's own estimates of assumptions that market participants would use in pricing the financial instrument. Valuation techniques include the use of option pricing models, discounted cash flow models, and similar techniques. The results cannot be determined with precision and may not be realized in an actual sale or immediate settlement of the financial instrument.

The Company bases its fair values on the price that would be received from the sale of a financial instrument in an orderly transaction between market participants at the measurement date under current market conditions. The Company maximizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value.

The following is a description of valuation methodologies used for financial instruments measured at fair value on a recurring basis.

AFS Securities - The Company's AFS securities portfolio is carried at estimated fair value. The majority of the securities within the AFS portfolio were issued by GSEs. The Company primarily uses prices obtained from third party pricing services to determine the fair value of its securities. On a quarterly basis, management corroborates a sample of prices obtained from the third party pricing service for Level 2 securities by comparing them to an independent source. If the price provided by the independent source varies by more than a predetermined percentage from the price received from the third party pricing service, then the variance is researched by management. The Company did not have to adjust prices obtained from the third party pricing service when determining the fair value of its securities during the three months ended December 31, 2019 or during fiscal year 2019. The Company's major security types, based on the nature and risks of the securities, are:

GSE Debentures - Estimated fair values are based on a discounted cash flow method. Cash flows are determined by taking any embedded options into consideration and are discounted using current market yields for similar securities. (Level 2)
MBS - Estimated fair values are based on a discounted cash flow method. Cash flows are determined based on prepayment projections of the underlying mortgages and are discounted using current market yields for benchmark securities. (Level 2)
Municipal Bonds - Estimated fair values are based on a discounted cash flow method. Cash flows are determined by taking any embedded options into consideration and are discounted using current market yields for securities with similar credit profiles. (Level 2)

Interest Rate Swaps - The Company's interest rate swaps are designated as cash flow hedges and are reported at fair value in other assets on the consolidated balance sheet if in a gain position, and in accounts payable and accrued expenses if in a loss position, with any unrealized gains and losses, net of taxes, reported as AOCI in stockholders' equity. See "Note 5. Borrowed Funds" for additional information. The estimated fair values of the interest rates swaps are obtained from the counterparty and are determined by a discounted cash flow analysis using observable market-based inputs. On a quarterly basis, management corroborates the estimated fair values by internally calculating the estimated fair value using a discounted cash flow analysis with independent observable market-based inputs from a third party. No changes were made to the estimated fair values during the three months ended December 31, 2019 or during fiscal year 2019. (Level 2)

The following tables provide the level of valuation assumption used to determine the carrying value of the Company's financial instruments measured at fair value on a recurring basis at the dates presented. The Company did not have any Level 3 financial instruments measured at fair value on a recurring basis at December 31, 2019 or September 30, 2019.
 
December 31, 2019
 
 
 
Quoted Prices
 
Significant
 
Significant
 
 
 
in Active Markets
 
Other Observable
 
Unobservable
 
Carrying
 
for Identical Assets
 
 Inputs
 
Inputs
 
Value
 
(Level 1)
 
(Level 2)
 
(Level 3)
 
(Dollars in thousands)
Assets:
 
 
 
 
 
 
 
AFS Securities:
 
 
 
 
 
 
 
MBS
$
937,317

 
$

 
$
937,317

 
$

GSE debentures
275,155

 

 
275,155

 

Municipal bonds
17,115

 

 
17,115

 

 
$
1,229,587

 
$

 
$
1,229,587

 
$

 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
Interest rate swaps
$
25,925

 
$

 
$
25,925

 
$


 
September 30, 2019
 
 
 
Quoted Prices
 
Significant
 
Significant
 
 
 
in Active Markets
 
Other Observable
 
Unobservable
 
Carrying
 
for Identical Assets
 
 Inputs
 
Inputs
 
Value
 
(Level 1)
 
(Level 2)
 
(Level 3)
 
(Dollars in thousands)
Assets:
 
 
 
 
 
 
 
AFS Securities:
 
 
 
 
 
 
 
MBS
$
936,487

 
$

 
$
936,487

 
$

GSE debentures
249,954

 

 
249,954

 

Municipal bonds
18,422

 

 
18,422

 

 
$
1,204,863

 
$

 
$
1,204,863

 
$

 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
Interest rate swaps
$
33,090

 
$

 
$
33,090

 
$



The following is a description of valuation methodologies used for significant financial instruments measured at fair value on a non-recurring basis.

Loans Receivable - The fair value of loans individually evaluated for impairment on a non-recurring basis during the three months ended December 31, 2019 and 2018 that were still held in the portfolio as of December 31, 2019 and 2018 was $3.9 million and $1.8 million, respectively.

The one- to four-family loans included in this amount were individually evaluated to determine if the carrying value of the loan was in excess of the fair value of the collateral, less estimated selling costs of 10%. Fair values were estimated through current appraisals. Management does not adjust or apply a discount to the appraised value of one- to four-family loans, except for the estimated sales cost noted above, and the primary unobservable input for these loans was the appraisal.

For commercial loans, if the most recent appraisal or book value of the collateral does not reflect the current market conditions due to the passage of time and/or other factors, management will make adjustments to the existing appraised or book value based on knowledge of local market conditions, recent transactions, and estimated selling costs, if applicable. Adjustments to appraised or book values are generally based on assumptions not observable in the marketplace. The primary significant unobservable inputs for
commercial loans individually evaluated for impairment during the three months ended December 31, 2019 were downward adjustments to the book value of the collateral for lack of marketability. The adjustments ranged from 10% to 50%, with a weighted average of 18%. There were no commercial loans individually evaluated during the three months ended December 31, 2018.

Fair values of loans individually evaluated for impairment cannot be determined with precision and may not be realized in an actual sale or immediate settlement of the loan and, as such, are classified as Level 3.

OREO - OREO primarily represents real estate acquired as a result of foreclosure or by deed in lieu of foreclosure and is carried at lower of cost or fair value. The fair value for OREO is estimated through current appraisals or listing prices, less estimated selling costs of 10%. Management does not adjust or apply a discount to the appraised value or listing price, except for the estimated sales costs noted above. The primary significant unobservable input for OREO was the appraisal or listing price. Fair values of foreclosed property cannot be determined with precision and may not be realized in an actual sale of the property and, as such, are classified as Level 3. The fair value of OREO measured on a non-recurring basis during the three months ended December 31, 2019 and 2018 that was still held in the portfolio as of December 31, 2019 and 2018 was $193 thousand and $192 thousand, respectively. The carrying value of the properties equaled the fair value of the properties at December 31, 2019 and 2018.

Fair Value Disclosures - The Company determined estimated fair value amounts using available market information and a variety of valuation methodologies as of the dates presented. Considerable judgment is required to interpret market data to develop the estimates of fair value. The estimates presented are not necessarily indicative of amounts the Company would realize from a current market exchange at subsequent dates.

The carrying amounts and estimated fair values of the Company's financial instruments by fair value hierarchy, at the dates presented, were as follows:
 
December 31, 2019
 
Carrying
 
Estimated Fair Value
 
Amount
 
Total
 
Level 1
 
Level 2
 
Level 3
 
(Dollars in thousands)
Assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
70,703

 
$
70,703

 
$
70,703

 
$

 
$

AFS securities
1,229,587

 
1,229,587

 

 
1,229,587

 

Loans receivable
7,429,207

 
7,646,224

 

 

 
7,646,224

FHLB stock
99,861

 
99,861

 
99,861

 

 

Liabilities:
 
 
 
 
 
 
 
 
 
Deposits
5,585,851

 
5,615,034

 
2,665,536

 
2,949,498

 

Borrowings
2,189,991

 
2,203,925

 
100,001

 
2,103,924

 

Interest rate swaps
25,925

 
25,925

 

 
25,925

 

 
 
 
 
 
 
 
 
 
 
 
September 30, 2019
 
Carrying
 
Estimated Fair Value
 
Amount
 
Total
 
Level 1
 
Level 2
 
Level 3
 
(Dollars in thousands)
Assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
220,370

 
$
220,370

 
$
220,370

 
$

 
$

AFS securities
1,204,863

 
1,204,863

 

 
1,204,863

 

Loans receivable
7,416,747

 
7,654,586

 

 

 
7,654,586

FHLB stock
98,456

 
98,456

 
98,456

 

 

Liabilities:
 
 
 
 
 
 
 
 
 
Deposits
5,581,867

 
5,614,895

 
2,594,242

 
3,020,653

 

Borrowings
2,239,989

 
2,253,353

 
100,001

 
2,153,352

 

Interest rate swaps
33,090

 
33,090

 

 
33,090